Toxicology in the ICU: Part 2: Specific toxins

Chest

Volumn 140, Issue 4, 2011, Pages 1072-1085

  Brooks, Daniel E ^a   Levine, Michael ^a   O'Connor, Ayrn D ^a   French, Robert N E ^a   Curry, Steven C ^a  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALCOHOL; ANESTHETIC AGENT; BACLOFEN; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CARBON MONOXIDE; CARISOPRODOL; CYANIDE; DEXTROMETHORPHAN; DIGOXIN; DIHYDROPYRIDINE; DILTIAZEM; HYPNOTIC SEDATIVE AGENT; KETAMINE; LITHIUM; LOW MOLECULAR WEIGHT HEPARIN; ORGANOPHOSPHATE; PARACETAMOL; PROPRANOLOL; PROTAMINE SULFATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SALICYLIC ACID; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SOTALOL; TOXIN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; WARFARIN; XENOBIOTIC AGENT;

BLEEDING; BLOOD TRANSFUSION; CARBON MONOXIDE INTOXICATION; CONTINUOUS INFUSION; CYANIDE POISONING; DRUG MECHANISM; DRUG OVERDOSE; FLUID RESUSCITATION; FULMINANT HEPATIC FAILURE; HEMODIALYSIS; HUMAN; HYPERBARIC OXYGEN; INTENSIVE CARE; INTENSIVE CARE UNIT; INTOXICATION; LIVER TOXICITY; LOADING DRUG DOSE; METHEMOGLOBINEMIA; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW; TOXICOLOGY; WITHDRAWAL SYNDROME;

EID: 80053536949     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-2726     Document Type: Review

References (169)

1. Zed PJ, Krenzelok EP. Treatment of acetaminophen overdose. Am J Health Syst Pharm. 1999;56(11):1081-1091.
2. Wilkes JM, Clark LE, Herrera JL. Acetaminophen overdose in pregnancy. South Med J. 2005;98(11):1118-1122. (Pubitemid 41780352)
3. Rumore MM, Blaiklock RG. Influence of age-dependent pharmacokinetics and metabolism on acetaminophen hepatotoxicity. J Pharm Sci. 1992;81(3):203-207.
4. Jones AF, Vale JA. Paracetamol poisoning and the kidney. J Clin Pharm Ther. 1993;18(1):5-8. (Pubitemid 23061259)
5. Rumack BH, Peterson RC, Koch GG, Amara IA. Acetaminophen overdose. 662 cases with evaluation of oral acetylcysteine treatment. Arch Intern Med. 1981;141(Spec No 3):380-385. (Pubitemid 11142902)
6. Prescott LF, Matthew H. Cysteamine for paracetamol overdosage. Lancet. 1974;1:998.
7. Prescott LF, Illingworth RN, Critchley JA, Stewart MJ, Adam RD, Proudfoot AT. Intravenous N-acetylcystine: the treatment of choice for paracetamol poisoning. BMJ. 1979;2(6198):1097-1100. (Pubitemid 10249121)
8. Bruno MK, Cohen SD, Khairallah EA. Antidotal effectiveness of N-acetylcysteine in reversing acetaminopheninduced hepatotoxicity. Enhancement of the proteolysis of arylated proteins. Biochem Pharmacol. 1988;37(22):4319- 4325. (Pubitemid 18265754)
9. Keays R, Harrison PM, Wendon JA, et al. Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial. BMJ. 1991;303(6809):1026-1029.
10. Betten DP, Burner EE, Thomas SC, Tomaszewski C, Clark RF. A retrospective evaluation of shortened-duration oral N-acetylcysteine for the treatment of acetaminophen poisoning. J Med Toxicol. 2009;5(4):183-190.
11. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97(2):439-445. (Pubitemid 19192181)
12. Raschke RA, Curry SC, Rempe S, et al. Results of a protocol for the management of patients with fulminant liver failure. Crit Care Med. 2008;36(8):2244-2248.
13. Yaffe SJ, Rane A, Sjöqvist F, Boréus LO, Orrenius S. The presence of a monooxygenase system in human fetal liver microsomes. Life Sci II. 1970;9(20):1189-1200.
14. Horowitz RS, Dart RC, Jarvie DR, Bearer CF, Gupta U. Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity. J Toxicol Clin Toxicol. 1997;35(5):447-451. (Pubitemid 27371415)
15. O'Malley GF. Emergency department management of the salicylate-poisoned patient. Emerg Med Clin North Am. 2007;25(2):333-346. (Pubitemid 46669881)
16. Rivera W, Kleinschmidt KC, Velez LI, Shepherd G, Keyes DC. Delayed salicylate toxicity at 35 hours without early manifestations following a single salicylate ingestion. Ann Pharmacother. 2004;38(7-8):1186-1188. (Pubitemid 38802158)
17. Tenney SM, Miller RM. The respiratory and circulatory actions of salicylate. Am J Med. 1055;19(4):498-508.
18. Silva PR, Fonseca-Costa A, Zin WA, Böddener A, Pinto TM. Respiratory and acid-base parameters during salicylic intoxication in dogs. Braz J Med Biol Res. 1986;19(2):279-286.
19. Curry SC, Pizon AF, Riley BD, Gerkin RD, Bikin DS. Effect of intravenous albumin infusion on brain salicylate concentration. Acad Emerg Med. 2007;14(6):508-514. (Pubitemid 46778890)
20. Stolbach AI, Hoffman RS, Nelson LS. Mechanical ventilation was associated with acidemia in a case series of salicylate-poisoned patients. Acad Emerg Med. 2008;15(9):866-869.
21. Thurston JH, Pollock PG, Warren SK, Jones EM. Reduced brain glucose with normal plasma glucose in salicylate poisoning. J Clin Invest. 1970;49(11):2139-2145.
22. Isbister GK, Hackett LP, Whyte IM. Intentional warfarin overdose. Ther Drug Monit. 2003;25(6):715-722. (Pubitemid 37499306)
23. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM; Warfarin Reversal Consensus Group. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust. 2004;181(9):492-497. (Pubitemid 39534470)
24. Ansell J, Hirsh J, Dalen J, et al. Managing oral anticoagulant therapy. Chest. 2001;119(suppl 1):22S-38S. (Pubitemid 32154193)
25. Baglin T. Management of warfarin (coumarin) overdose. Blood Rev. 1998;12(2):91-98. (Pubitemid 28327415)
26. Geiger J, Teichmann L, Grossmann R, et al. Monitoring of clopidogrel action: comparison of methods. Clin Chem. 2005;51(6):957-965. (Pubitemid 40740875)
27. Gresham C, Levine M, Ruha AM. Case files of the medical toxicology fellowship at Banner Good Samaritan Medical Center in Phoenix, AZ: a non-warfarin anticoagulant overdose. J Med Toxicol. 2009;5(4):242-249.
28. Menajovsky LB. Heparin-induced thrombocytopenia: clinical manifestations and management strategies. Am J Med. 2005;118(suppl 8A):21S-30S. (Pubitemid 41207328)
29. Pearigen PD, Benowitz NL. Poisoning due to calcium antagonists. Experience with verapamil, diltiazem and nifedipine. Drug Saf. 1991;6(6):408-430.
30. Levine M, Boyer EW, Pozner CN, et al. Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. Crit Care Med. 2007;35(9):2071-2075. (Pubitemid 47326443)
31. Olson KR, Erdman AR, Woolf AD, et al. Calcium channel blocker ingestion: An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol. 2005;43(7):792-822.
32. Levine M, Brooks DE, Truitt CA, Wolk BJ, Boyer EW, Ruha A-M. Toxicology in the ICU: part I: general overview and approach to treatment. Chest. 2011;140(3):795-806.
33. Holzer M, Sterz F, Schoerkhuber W, et al. Successful resuscitation of a verapamil-intoxicated patient with percutaneous cardiopulmonary bypass. Crit Care Med. 1999;27(12):2818-2823. (Pubitemid 30027203)
34. Hendren WG, Schieber RS, Garrettson LK. Extracorporeal bypass for the treatment of verapamil poisoning. Ann Emerg Med. 1989;18(9):984-987. (Pubitemid 19216832)
35. Janion M, Stepień A, Sielski J, Gutkowski W. Is the intraaortic balloon pump a method of brain protection during cardiogenic shock after drug intoxication? J Emerg Med. 2010;38(2):162-167.
36. Baud FJ, Megarbane B, Deye N, Leprince P. Clinical review: aggressive management and extracorporeal support for drug-induced cardiotoxicity. Crit Care. 2007;11(2):207.
37. Brodde OE, Bruck H, Leineweber K. Cardiac adrenoreceptors: physiologic and pathophysiologic relevance. J Pharm Sci. 2006;100(5):323-327.
38. Nies AS, Shand DG. Clinical pharmacology of propranolol. Circulation. 1975;52(1):6-15.
39. Sangster B, De Wildt D, Van Dijk A, Klein S. A case of acebutolol intoxication. J Toxicol Clin Toxicol. 1983;20(1):69-77. (Pubitemid 13005716)
40. Reith DM, Dawson AH, Epid D, Whyte IM, Buckley NA, Sayer GP. Relative toxicity of beta blockers in overdose. J Toxicol Clin Toxicol. 1996;34(3):273-278. (Pubitemid 26199207)
41. Neuvonen PJ, Elonen E, Vuorenmaa T, Laakso M. Prolonged Q-T interval and severe tachyarrhythmias, common features of sotalol intoxication. Eur J Clin Pharmacol. 1981;20(2):85-89. (Pubitemid 11083293)
42. Wax PM, Erdman AR, Chyka PA, et al. b -blocker ingestion: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2005;43(3):131-146. (Pubitemid 40675645)
43. Glick G, Parmley WW, Wechsler AS, Sonnenblick EH. Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol. Circ Res. 1968;22(6):789-799.
44. Lucchesi BR. Cardiac actions of glucagon. Circ Res. 1968;22(6):777-787.
45. Benvenisty AI, Spotnitz HM, Rose EA, Malm JR, Hoffman BF. Antagonism of chronic canine beta-adrenergic blockade with dopamine-isoproterenol, dobutamine, and glucagon. Surg Forum. 1979;30:187-188. (Pubitemid 10144804)
46. Yao L, Macleod KM, McNeil JH. Glucagon-induced desensitization: Correlation between cyclic AMP levels and contractile force. Eur J Pharmacol. 1982;79(1-2):147-150. (Pubitemid 12149437)
47. Juan-Fita MJ, Vargas ML, Kaumann AJ, Hernández Cascales J. Rolipram reduces the inotropic tachyphylaxis of glucagon in rat ventricular myocardium. Naunyn Schmiedebergs Arch Pharmacol. 2004;370(4):324-329. (Pubitemid 40063833)
48. Smith TW. Digitalis. Mechanisms of action and clinical use. N Engl J Med. 1988;318(6):358-365. (Pubitemid 18044166)
49. Ma G, Brady WJ, Pollack M, Chan TC. Electrocardiographic manifestations: digitalis toxicity. J Emerg Med. 2001;20(2):145-152. (Pubitemid 32149616)
50. Bismuth C, Gaultier M, Conso F, Efthymiou ML. Hyperkalemia in acute digitalis poisoning: prognostic significance and therapeutic implications. Clin Toxicol. 1973;6(2):153-162.
51. Lip GYH, Metcalfe MJ, Dunn FG. Diagnosis and treatment of digoxin toxicity. Postgrad Med J. 1993;69(811):337-339. (Pubitemid 23174764)
52. DigiFab [package insert], revised. Protherics Inc.; 2008. http://www.fougera.com/products/crofab-digifab/digifab-packageinsert.pdf. Accessed January 4, 2011.
53. Eyer F, Steimer W, Müller C, Zilker T. Free and total digoxin in serum during treatment of acute digoxin poisoning with Fab fragments: case study. Am J Crit Care. 2010;19(4):387-391.
54. Ujhelyi MR, Robert S, Cummings DM, et al. Disposition of digoxin immune Fab in patients with kidney failure. Clin Pharmacol Ther. 1993;54(4):388-394. (Pubitemid 23316175)
55. Blanke O, Landis T, Spinelli L, Seeck M. Out-of-body experience and autoscopy of neurological origin. Brain. 2004;127(pt 2):243-258. (Pubitemid 38160310)
56. Kohrs R, Durieux ME. Ketamine: teaching an old drug new tricks. Anesth Analg. 1998;87(5):1186-1193. (Pubitemid 28501183)
57. Dickerson DL, Schaepper MA, Peterson MD, Ashworth MD. Coricidin HBP abuse: patient characteristics and psychiatric manifestations as recorded in an inpatient psychiatric unit. J Addict Dis. 2008;27(1):25-32.
58. Boyer EW. Dextromethorphan abuse. Pediatr Emerg Care. 2004;20(12):858-863. (Pubitemid 40039880)
59. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005;352(11):1112-1120.
60. Schwartz AR, Pizon AF, Brooks DE. Dextromethorphaninduced serotonin syndrome. Clin Toxicol (Phila). 2008;46(8):771-773.
61. Ganetsky M, Babu KM, Boyer EW. Serotonin syndrome in dextromethorphan ingestion responsive to propofol therapy. Pediatr Emerg Care. 2007;23(11):829-831. (Pubitemid 350145279)
62. Hendrickson RG, Cloutier RL. "Crystal dex:" free-base dextromethorphan. J Emerg Med. 2007;32(4):393-396.
63. Chyka PA, Erdman AR, Manoguerra AS, et al; American Association of Poison Control Centers. Dextromethorphan poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol (Phila). 2007;45(6):662-677. (Pubitemid 47394415)
64. Tucciarone M, Dileo PA, Castro ER, Guerrero M. Myocardial infarction secondary to carbon monoxide poisoning: an uncommon presentation of a common condition. Case report and review of the literature. Am J Ther. 2009;16(5):462-465.
65. Lee D, Hsu TL, Chen CH, Wang SP, Chang MS. Myocardial infarction with normal coronary artery after carbon monoxide exposure: a case report. Zhonghua Yi Xue Za Zhi (Taipei). 1996;57(5):355-359.
66. Tritapepe L, Macchiarelli G, Rocco M, et al. Functional and ultrastructural evidence of myocardial stunning after acute carbon monoxide poisoning. Crit Care Med. 1998;26(4):797-801. (Pubitemid 28201430)
67. Hardy KR, Thom SR. Pathophysiology and treatment of carbon monoxide poisoning. J Toxicol Clin Toxicol. 1994;32(6):613-629. (Pubitemid 24372548)
68. Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. 2002;347(14):1057-1067.
69. Scheinkestel CD, Jones K, Myles PS, Cooper DJ, Millar IL, Tuxen DV. Where to now with carbon monoxide poisoning? Emerg Med Australas. 2004;16(2):151-154. (Pubitemid 38595825)
70. Gilmer B, Kilkenny J, Tomaszewski C, Watts JA. Hyperbaric oxygen does not prevent neurologic sequelae after carbon monoxide poisoning. Acad Emerg Med. 2002;9(1):1-8. (Pubitemid 34049220)
71. Scheinkestel CD, Bailey M, Myles PS, et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Med J Aust. 1999;170(5):203-210. (Pubitemid 29112648)
72. Chang DC, Lee JT, Lo CP, et al. Hyperbaric oxygen ameliorates delayed neuropsychiatric syndrome of carbon monoxide poisoning. Undersea Hyperb Med. 2010;37(1):23-33.
73. Gabrielli A, Layon AJ. Carbon monoxide intoxication during pregnancy: a case presentation and pathophysiologic discussion, with emphasis on molecular mechanisms. J Clin Anesth. 1995;7(1):82-87.
74. Margulies JL. Acute carbon monoxide poisoning during pregnancy. Am J Emerg Med. 1986;4(6):516-519. (Pubitemid 17222680)
75. Mandal NG, White N, Wee MYK. Carbon monoxide poisoning in a parturient and the use of hyperbaric oxygen for treatment. Int J Obstet Anesth. 2001;10(1):71-74. (Pubitemid 32059861)
76. Annane D, Chadda K, Gajdos P, Jars-Guincestre MC, Chevret S, Raphael JC. Hyperbaric oxygen therapy for acute domestic carbon monoxide poisoning: two randomized controlled trials. Intensive Care Med. 2011;37(3):486-492.
77. American College of Emergency Medicine Physicians. Clinical policy: critical issues in the management of adult patients presenting to the emergency department with acute carbon monoxide poisoning. www.acep.org/WorkArea/ DownloadAsset.aspx?id=33724. Accessed August 7, 2011.
78. Tsubaki M. Fourier-transform infrared study of cyanide binding to the Fea3-CuB binuclear site of bovine heart cytochrome c oxidase: implication of the redox-linked conformational change at the binuclear site. Biochemistry. 1993;32(1):164-173. (Pubitemid 23033333)
79. Curry SC, Patrick HC. Lack of evidence for a percent saturation gap in cyanide poisoning. Ann Emerg Med. 1991;20(5):523-528.
80. Wexler J, Whittenberger JL, Dumke PR. The effect of cyanide on the electrocardiogram of man. Am Heart J. 1947;34(2):163-173.
81. Chen KK, Rose RL, Clowes GHA. Methylene blue (methylthionine chloride), nitrites and sodium thiosulphate against cyanide poisoning. Proc Soc Exp Biol Med. 1933;31:250-251.
82. Katz KD, Ruha AM, Curry SC. Aniline and methanol toxicity after shoe dye ingestion. J Emerg Med. 2004;27(4):367-369. (Pubitemid 39388674)
83. Luk G, Riggs D, Luque M. Severe methemoglobinemia in a 3-week-old infant with a urinary tract infection. Crit Care Med. 1991;19(10):1325-1327.
84. Rosen PJ, Johnson C, McGehee WG, Beutler E. Failure of methylene blue treatment in toxic methemoglobinemia. Association with glucose-6-phosphate dehydrogenase deficiency. Ann Intern Med. 1971;75(1):83-86.
85. Curry S. Methemoglobinemia. Ann Emerg Med. 1982;11(4):214-221.
86. Haymond S, Cariappa R, Eby CS, Scott MG. Laboratory assessment of oxygenation in methemoglobinemia. Clin Chem. 2005;51(2):434-444. (Pubitemid 40175815)
87. Karadsheh NS, Shaker Q, Ratroat B. Metoclopramide-induced methemoglobinemia in a patient with co-existing deficiency of glucose-6-phosphate dehydrogenase and NADH-cytochrome b5 reductase: failure of methylene blue treatment. Haematologica. 2001;86(6):659-660. (Pubitemid 32601112)
88. Yurumez Y, Durukan P, Yavuz Y, et al. Acute organophosphate poisoning in university hospital emergency room patients. Intern Med. 2007;46(13):965-969. (Pubitemid 47261639)
89. Holmstedt B. Pharmacology of organophosphorus cholinesterase inhibitors. Pharmacol Rev. 1959;11:567-688.
90. Moretto A. Experimental and clinical toxicology of anticholinesterase agents. Toxicol Lett. 1998;102-103:509-513. (Pubitemid 29021270)
91. Jayawardane P, Dawson AH, Weerasinghe V, Karalliedde L, Buckley NA, Senanayake N. The spectrum of intermediate syndrome following acute organophosphate poisoning: a prospective cohort study from Sri Lanka. PLoS Med. 2008;5(7):e147.
92. Geller RJ, Lopez GP, Cutler S, Lin D, Bachman GF, Gorman SE. Atropine availability as an antidote for nerve agent casualties: validated rapid reformulation of high-concentration atropine from bulk powder. Ann Emerg Med. 2003;41(4):453-456. (Pubitemid 36373510)
93. Dippenaar R, Diedericks RJ. Paediatric organophosphate poisoning - a rural hospital experience. S Afr Med J. 2005;95(9):678-681. (Pubitemid 41440277)
94. Selden BS, Curry SC. Prolonged succinylcholine-induced paralysis in organophosphate insecticide poisoning. Ann Emerg Med. 1987;16(2):215-217. (Pubitemid 17015205)
95. De Silva HJ, Wijewickrema R, Senanayake N. Does pralidoxime affect outcome of management in acute organophosphorus poisoning? Lancet. 1992;339(8802):1136-1138.
96. Pawar KS, Bhoite RR, Pillay CP, Chavan SC, Malshikare DS, Garad SG. Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomised controlled trial. Lancet. 2006;368(9553):2136-2141. (Pubitemid 44894558)
97. Peter JV, Moran JL, Graham P. Oxime therapy and outcomes in human organophosphate poisoning: an evaluation using meta-analytic techniques. Crit Care Med. 2006;34(2):502-510. (Pubitemid 43145632)
98. Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(1):85-102. (Pubitemid 36131110)
99. Barbey JT, Roose SP. SSRI safety in overdose. J Clin Psychiatry. 1998;59(suppl 15):42-48. (Pubitemid 28467477)
100. Starr P, Klein-Schwartz W, Spiller H, Kern P, Ekleberry SE, Kunkel S. Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med. 2009;27(8):911-915.
101. Yilmaz Z, Ceschi A, Rauber-Luthy C, et al. Escitalopram causes fewer seizures in human overdose than citalopram. Clin Toxicol. 2010;48(3):201-212.
102. Hayes BD, Klein-Schwartz W, Clark RF, Muller AA, Miloradovich JE. Comparison of toxicity of acute overdoses with citalopram and escitalopram. J Emerg Med. 2010;39(1):44-48.
103. Buckley NA, Faunce TA. 'Atypical' antidepressants in overdose: clinical considerations with respect to safety. Drug Saf. 2003;26(8):539-551. (Pubitemid 36724095)
104. Whyte IM, Dawson AH, Buckley NA. Relative toxicity of venlafaxine and selective serotonin reuptake inhibitors in overdose compared to tricyclic antidepressants. QJM. 2003;96(5):369-374. (Pubitemid 36592709)
105. Bosse GM, Spiller HA, Collins AM. A fatal case of venlafaxine overdose. J Med Toxicol. 2008;4(1):18-20.
106. Desarkar P, Das A, Das B, Sinha VK. Lithium toxicity presenting as catatonia in an adolescent girl. J Clin Psychopharmacol. 2007;27(4):410-412. (Pubitemid 47075521)
107. Buckley NA, McManus PR. Can the fatal toxicity of antidepressant drugs be predicted with pharmacological and toxicological data? Drug Saf. 1998;18(5):369-381. (Pubitemid 28206015)
108. Thanacoody HK, Thomas SH. Tricyclic antidepressant poisoning: cardiovascular toxicity. Toxicol Rev. 2005;24(3):205-214. (Pubitemid 43060627)
109. Preskorn SH. Pharmacokinetics of antidepressants: why and how they are relevant to treatment. J Clin Psychiatry. 1993;54(suppl):14-34. (Pubitemid 23320768)
110. Kerr GW, McGuffie AC, Wilkie S. Tricyclic antidepressant overdose: a review. Emerg Med J. 2001;18(4):236-241. (Pubitemid 34070918)
111. Harvey M, Cave G. Intralipid outperforms sodium bicarbonate in a rabbit model of clomipramine toxicity. Ann Emerg Med. 2007;49(2):178-185.
112. Dunner DL. Optimizing lithium treatment. J Clin Psychiatry. 2000;61(suppl 9):76-81. (Pubitemid 30453891)
113. Thomas M, Boggs AA, DiPaula B, Siddiqi S. Adverse drug reactions in hospitalized psychiatric patients. Ann Pharmacother. 2010;44(5):819-825.
114. Harvey NS, Merriman S. Review of clinically important drug interactions with lithium. Drug Saf. 1994;10(6):455-463. (Pubitemid 24191868)
115. Finley PR, Warner MD, Peabody CA. Clinical relevance of drug interactions with lithium. Clin Pharmacokinet. 1995;29(3):172-191.
116. Juurlink DN, Mamdani MM, Kopp A, Rochon PA, Shulman KI, Redelmeier DA. Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc. 2004;52(5):794-798. (Pubitemid 38596502)
117. Yip KK, Yeung WT. Lithium overdose causing non-convulsive status epilepticus - the importance of lithium levels and the electroencephalography in diagnosis. Hong Kong Med J. 2007;13(6):471-474. (Pubitemid 351206682)
118. Tilkian AG, Schroeder JS, Kao JJ, Hultgren HN. The cardiovascular effects of lithium in man. A review of the literature. Am J Med. 1976;61(5):665-670.
119. Mamiya K, Sadanaga T, Sekita A, Nabeyama Y, Yao H, Yukawa E. Lithium concentration correlates with QTc in patients with psychosis. J Electrocardiol. 2005;38(2):148-151. (Pubitemid 40616140)
120. Waring WS. Delayed cardiotoxicity in chronic lithium poisoning: discrepancy between serum lithium concentrations and clinical status. Basic Clin Pharmacol Toxicol. 2007;100(5):353-355. (Pubitemid 46633479)
121. White B, Larry J, Kantharia BK. Protracted presyncope and profound bradycardia due to lithium toxicity. Int J Cardiol. 2008;125(3):e48-e50. (Pubitemid 351418029)
122. Puhr J, Hack J, Early J, Price W, Meggs W. Lithium overdose with electrocardiogram changes suggesting ischemia. J Med Toxicol. 2008;4(3):170-172.
123. Serinken M, Karcioglu O, Korkmaz A. Rarely seen cardiotoxicity of lithium overdose: complete heart block. Int J Cardiol. 2009;132(2):276-278.
124. Mateer JR, Clark MR. Lithium toxicity with rarely reported ECG manifestations. Ann Emerg Med. 1982;11(4):208-211.
125. Grünfeld JP, Rossier BC. Lithium nephrotoxicity revisited. Nat Rev Nephrol. 2009;5(5):270-276.
126. Saunders BD, Saunders EF, Gauger PG. Lithium therapy and hyperparathyroidism: an evidence-based assessment. World J Surg. 2009;33(11):2314-2323.
127. Lazarus JH. Lithium and thyroid. Best Pract Res Clin Endocrinol Metab. 2009;23(6):723-733.
128. Bailey B, McGuigan M. Lithium poisoning from a poison control center perspective. Ther Drug Monit. 2000;22(6):650-655.
129. Vermeire S, Vanbrabant P, Van Boxstael P, Sabbe M. Severity (and treatment) of chronic lithium poisoning: clinical signs or lab results as a criterion? Acta Clin Belg. 2010;65(2):127-128.
130. Amdisen A. Clinical features and management of lithium poisoning. Med Toxicol Adverse Drug Exp. 1988;3(1):18-32. (Pubitemid 18078194)
131. Eyer F, Pfab R, Felgenhauer N, et al. Lithium poisoning: pharmacokinetics and clearance during different therapeutic measures. J Clin Psychopharmacol. 2006;26(3):325-330. (Pubitemid 43804627)
132. Perry HE, Wright RO, Shannon MW, Woolf AD. Baclofen overdose: drug experimentation in a group of adolescents. Pediatrics. 1998;101(6):1045-1048. (Pubitemid 28248891)
133. Graham SR, Day RO, Lee R, Fulde GW. Overdose with chloral hydrate: a pharmacological and therapeutic review. Med J Aust. 1988;149(11-12):686-688. (Pubitemid 19023438)
134. Lee DC, Vassalluzzo C. Acute gastric perforation in a chloral hydrate overdose. Am J Emerg Med. 1998;16(5):545-546. (Pubitemid 28385631)
135. Veller ID, Richardson JP, Doyle JC, Keating M. Gastric necrosis: a rare complication of chloral hydrate intoxication. Br J Surg. 1972;59(4):317-319.
136. Gleich GJ, Mongan ES, Vaules DW. Esophageal stricture following chloral hydrate poisoning. JAMA. 1967;201(4):266-267.
137. Gerretsen M, De Groot G, Van Heijst ANP, Maes RA. Chloral hydrate poisoning: its mechanism and therapy. Vet Hum Toxicol. 1979;21(suppl):53-56. (Pubitemid 10199801)
138. Ludwigs U, Divino Filho JC, Magnusson A, Berg A. Suicidal chloral hydrate poisoning. J Toxicol Clin Toxicol. 1996;34(1):97-99. (Pubitemid 26060355)
139. Zahedi A, Grant MH, Wong DT. Successful treatment of chloral hydrate cardiac toxicity with propranolol. Am J Emerg Med. 1999;17(5):490-491. (Pubitemid 29428524)
140. Bowyer K, Glasser SP. Chloral hydrate overdose and cardiac arrhythmias. Chest. 1980;77(2):232-235. (Pubitemid 10164267)
141. Sing K, Erickson T, Amitai Y, Hryhorczuk D. Chloral hydrate toxicity from oral and intravenous administration. J Toxicol Clin Toxicol. 1996;34(1):101-106. (Pubitemid 26060356)
142. Shannon M, Quang LS. Gamma-hydroxybutyrate, gammabutyrolactone, and 1,4-butanediol: a case report and review of the literature. Pediatr Emerg Care. 2000;16(6):435-440.
143. Wood DM, Warren-Gash C, Ashraf T, et al. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD). QJM. 2008;101(1):23-29.
144. Brent J. Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med. 2009;360(21):2216-2223.
145. Adla MR, Gonzalez-Paoli JA, Rifkin SI. Isopropyl alcohol ingestion presenting as pseudorenal failure due to acetone interference. South Med J. 2009;102(8):867-869.
146. Jacobsen D, Ovrebø S, Ostborg J, Sejersted OM. Glycolate causes the acidosis in ethylene glycol poisoning and is effectively removed by hemodialysis. Acta Med Scand. 1984;216(4):409-416. (Pubitemid 15182237)
147. Hovda KE, Guo C, Austin R, McMartin KE. Renal toxicity of ethylene glycol results from internalization of calcium oxalate crystals by proximal tubule cells. Toxicol Lett. 2010;192(3):365-372.
148. Eells JT, Henry MM, Lewandowski MF, Seme MT, Murray TG. Development and characterization of a rodent model of methanol-induced retinal and optic nerve toxicity. Neurotoxicology. 2000;21(3):321-330. (Pubitemid 30436431)
149. Karayel F, Turan AA, Sav A, Pakis I, Akyildiz EU, Ersoy G. Methanol intoxication: pathological changes of central nervous system (17 cases). Am J Forensic Med Pathol. 2010;31(1):34-36.
150. Taheri MS, Moghaddam HH, Moharamzad Y, Dadgari S, Nahvi V. The value of brain CT findings in acute methanol toxicity. Eur J Radiol. 2010;73(2):211-214.
151. Lepik KJ, Levy AR, Sobolev BG, et al. Adverse drug events associated with the antidotes for methanol and ethylene glycol poisoning: a comparison of ethanol and fomepizole. Ann Emerg Med. 2009;53(4):439-450., e10.
152. Jacobsen D, Webb R, Collins TD, McMartin KE. Methanol and formate kinetics in late diagnosed methanol intoxication. Med Toxicol. 1988;3(5):418-423.
153. Nath R, Thind SK, Murthy MS, Farooqui S, Gupta R, Koul HK. Role of pyridoxine in oxalate metabolism. Ann N Y Acad Sci. 1990;585:274-284. (Pubitemid 20175904)
154. Noker PE, Tephly TR. The role of folates in methanol toxicity. Adv Exp Med Biol. 1980;132:305-315.
155. Barceloux DG, Krenzelok EP, Olson K, Watson W; Ad Hoc Committee. American Academy of Clinical Toxicology Practice Guidelines on the Treatment of Ethylene Glycol Poisoning. J Toxicol Clin Toxicol. 1999;37(5):537-560.
156. Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA. American Academy of Clinical Toxicology Ad Hoc Committee on the Treatment Guidelines for Methanol Poisoning. American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. Clin Toxicol. 2002;40(4):415-446.
157. Caravati EM, Heileson HL, Jones M. Treatment of severe pediatric ethylene glycol intoxication without hemodialysis. J Toxicol Clin Toxicol. 2004;42(3):255-259. (Pubitemid 39166752)
158. Hovda KE, Jacobsen D. Expert opinion: fomepizole may ameliorate the need for hemodialysis in methanol poisoning. Hum Exp Toxicol. 2008;27(7):539-546.
159. Levine M, Ruha A, Curry SC, Bikin D. Ethylene glycol serum elimination half-life in patients treated with fomepizole but without hemodialysis. Ann Emerg Med. 2010;56(suppl 3):S124.
160. Pizon AF, Brooks DE. Hyperosmolality: another indication for hemodialysis following acute ethylene glycol poisoning. Clin Toxicol (Phila). 2006;44(2):181-183.
161. Brent J. Current management of ethylene glycol poisoning. Drugs. 2001;61(7):979-988. (Pubitemid 32575397)
162. Amato L, Minozzi S, Vecchi S, Davoli M. Benzodiazepines for alcohol withdrawal. Cochrane Database Syst Rev. 2010;(3):CD005063.
163. Weaver MF, Hoffman HJ, Johnson RE, Mauck K. Alcohol withdrawal pharmacotherapy for inpatients with medical comorbidity. J Addict Dis. 2006;25(2):17-24. (Pubitemid 44157064)
164. Mayo-Smith MF, Beecher LH, Fischer TL, et al; Working Group on the Management of Alcohol Withdrawal Delirium, Practice Guidelines Committee, American Society of Addiction Medicine. Management of alcohol withdrawal delirium. An evidence-based practice guideline [published correction appears in Arch Intern Med 2004;164(18):2068]. Arch Intern Med. 2004;164(13):1405-1412.
165. Institute of Medicine. Prevention and Treatment of Alcohol Problems. Washington, DC: National Academy Press; 1990:268-269.
166. Shirley KW, Kothare S, Piatt JH Jr, Adirim TA. Intrathecal baclofen overdose and withdrawal. Pediatr Emerg Care. 2006;22(4):258-261. (Pubitemid 43772178)
167. Dario A, Tomei G. A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf. 2004;27(11):799-818. (Pubitemid 39243562)
168. Amato L, Davoli M, Minozzi S, Ali R, Ferri M. Methadone at tapered doses for the management of opioid withdrawal. Cochrane Database Syst Rev. 2005;(3):CD003409.
169. Gowing L, Ali R, White JM. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev. 2009;(3):CD002025.